TINAVI Medical Technologies Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 55.42 million compared to CNY 72.21 million a year ago. Revenue was CNY 60.95 million compared to CNY 76.4 million a year ago.

Net loss was CNY 44.18 million compared to CNY 38.71 million a year ago. Basic loss per share from continuing operations was CNY 0.11 compared to CNY 0.09 a year ago. Diluted loss per share from continuing operations was CNY 0.11 compared to CNY 0.09 a year ago.